Agios Pharmaceuticals Price Target Hiked to $34.00

Agios Pharmaceuticals' (NASDAQ:AGIO) price target has been raised to $34.00 by JPMorgan Chase & Co., a significant increase from their previous target of $31.00. This change indicates a potential upside of 7.19% from the stock's previous close.

JPMorgan Chase & Co.'s report was not the only update on Agios Pharmaceuticals' price targets. Other analysts have also made changes, with Royal Bank Of Canada increasing their target to $32.00 and Bank of America raising theirs to $46.00. However, some analysts remain cautious, as evidenced by Weiss Ratings reaffirming a 'sell (d)' rating.

Agios Pharmaceuticals' stock has seen its fair share of activity, with shares trading down 0.7% on Friday at $31.72. The company's market capitalization stands at $1.89 billion, and it has a price-to-earnings ratio of -4.52.